Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CYTOSORBENTS MEDICAL INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-06-15 to 2023-10-14
Current total value of award: $2897172
Description: CYTOSORBENTS DHA STTR RIF PHASE III - DHP15B-001-P-6144 DEVELOPMENT OF A HIGHLY EFFICIENT ADSORBER TO REMOVE ANTI-A AND ANTI-B ANTIBODIES FROM BLOOD AND PLASMA FOR TRANSFUSION